The impact of a cancer Survivorship Care Plan on gynecological cancer patient and health care provider reported outcomes (ROGY Care): study protocol for a pragmatic cluster randomized controlled trial

Lonneke V van de Poll-Franse, Kim A H Nicolaije, Maria C Vos, Johanna M A Pijnenborg, Dorry Boll, Olga Husson, Nicole P M Ezendam, Erik A Boss, Ralph H M Hermans, Karin C M Engelhart, Joke E Haartsen, Brenda M Pijlman, Harrie W H Feijen, Helena J M M Mertens, Willem E Nolting, Johannes J van Beek, Jan A Roukema, Roy F P M Kruitwagen, Lonneke V van de Poll-Franse, Kim A H Nicolaije, Maria C Vos, Johanna M A Pijnenborg, Dorry Boll, Olga Husson, Nicole P M Ezendam, Erik A Boss, Ralph H M Hermans, Karin C M Engelhart, Joke E Haartsen, Brenda M Pijlman, Harrie W H Feijen, Helena J M M Mertens, Willem E Nolting, Johannes J van Beek, Jan A Roukema, Roy F P M Kruitwagen

Abstract

Background: There is a need for improvement of information provision and post-treatment care for cancer survivors. A Survivorship Care Plan (SCP) is recommended by the American Institute of Medicine and the Dutch Health Council, which is a summary of patients' course of treatment as a formal document, and includes recommendations for subsequent cancer surveillance, management of late effects, and strategies for health promotion. Until now, evidence on the effects of implementing the SCP in clinical practice is lacking. The rationale and study design of a pragmatic cluster randomized trial, aiming to assess the impact of SCP care in routine clinical practice, is presented.

Methods/design: A web-based patient registration system 'Registrationsystem Oncological GYnecology' (ROGY) is used by gynecologists in the South of the Netherlands since 2006. A personalized SCP can automatically be generated out of ROGY. In this pragmatic cluster randomized controlled trial, 12 hospitals are randomized to either 'usual care' or 'SCP care'. In patients with 'usual care', the gynecologist provides care as usual. In patients with 'SCP care', information about the tumor stage and treatment is personally discussed with the patient and a document is handed to the patient. Prospectively, all patients diagnosed with endometrial or ovarian cancer in the participating hospitals will be approached for study participation. Patients will complete questionnaires after surgery, and before additional treatment, and after 6, 12, 18 and 24 months. In addition, health care providers will be asked their opinion about implementation of SCP care. Primary outcome is defined as patient satisfaction with information provision and care. Secondary outcomes are illness perception, health-related quality of life, health care use, prevalence, course and referral rate of survivors with psychosocial distress, and health care providers' evaluation of SCP care.

Discussion: The ROGY Care trial will help to gain insight into the impact of SCP care on patient reported outcomes, and on the evaluation of cancer survivors and health care providers of the different elements of the SCP. Therefore, results will contribute to efforts to improve quality of care for cancer survivors.

Trial registration: Trial Registration: http://www.ClinicalTrials.gov. Identifier: NCT01185626 Medical Research Ethics Committee Reference Number: NL33429.008.10 Grant Reference Number: UVT2010-4743.

References

    1. Signaleringscommissie kanker van KWF Kankerbestrijding. Kanker in Nederland. Trends, prognoses en implicaties voor zorgvraag. Amsterdam; 2004.
    1. Ayanian JZ, Jacobsen PB. Enhancing research on cancer survivors. J Clin Oncol. 2006;24:5149–5153. doi: 10.1200/JCO.2006.06.7207.
    1. Gotay CC, Muraoka MY. Quality of life in long-term survivors of adult-onset cancers. J Natl Cancer Inst. 1998;90:656–667. doi: 10.1093/jnci/90.9.656.
    1. Health Council of the Netherlands. Follow-up in oncology. Identify objectives, substantiate actions. The Hague; 2007.
    1. Mesters I, van den Borne B, De Boer M, Pruyn J. Measuring information needs among cancer patients. Patient Educ Couns. 2001;43:253–262.
    1. Davies NJ, Kinman G, Thomas RJ, Bailey T. Information satisfaction in breast and prostate cancer patients: implications for quality of life. Psychooncology. 2008;17:1048–1052. doi: 10.1002/pon.1305.
    1. Hesse BW, Arora NK, Burke Beckjord E, Finney Rutten LJ. Information support for cancer survivors. Cancer. 2008;112:2529–2540. doi: 10.1002/cncr.23445.
    1. Meredith C, Symonds P, Webster L, Lamont D, Pyper E, Gillis CR, Fallowfield L. Information needs of cancer patients in west Scotland: cross sectional survey of patients' views. BMJ. 1996;313:724–726. doi: 10.1136/bmj.313.7059.724.
    1. Beckjord EB, Arora NK, McLaughlin W, Oakley-Girvan I, Hamilton AS, Hesse BW. Health-related information needs in a large and diverse sample of adult cancer survivors: implications for cancer care. J Cancer Surviv. 2008;2:179–189. doi: 10.1007/s11764-008-0055-0.
    1. Jenkins V, Fallowfield L, Saul J. Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer. 2001;84:48–51. doi: 10.1054/bjoc.2000.1573.
    1. Lagarde SM, Franssen SJ, van Werven JR, Smets EM, Tran TC, Tilanus HW, Plukker JT, de Haes JC, van Lanschot JJ. Patient preferences for the disclosure of prognosis after esophagectomy for cancer with curative intent. Ann Surg Oncol. 2008;15:3289–3298. doi: 10.1245/s10434-008-0068-y.
    1. Husson O, Mols F, van de Poll-Franse LV. The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review. Annals of Oncology. in press .
    1. Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: Lost in transition. Washington, DC; 2006.
    1. Tan ASL, Bourgoin A, Gray SW, Armstrong K, Hornik RC. How does patient-clinician information engagement influence self-reported cancer-related problems? Cancer. in press .
    1. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D. for the CONSORT and Pragmatic Trials in Healthcare (Practihc) groups. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390. doi: 10.1136/bmj.a2390.
    1. Campbell MK, Elbourne DR, Altman DG. for the CONSORT group. CONSORT statement: extension to cluster randomized trials. BMJ. 2004;328:702–708. doi: 10.1136/bmj.328.7441.702.
    1. van de Poll-Franse LV, Horevoorts N, van Eenbergen M, Denollet J, Roukema JA, Aaronson NK, Coebergh JW, de Vries J, Essink-Bot M-L, Mols F. The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: Scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer. 2011. in press .
    1. Schellings R, Kessels AG, Sturmans F. Pre-randomisation in study designs: getting past the taboo. Ned Tijdschr Geneeskd. 2008;152:2053–2056.
    1. Ganz PA, Hahn EE. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008;26:759–767. doi: 10.1200/JCO.2007.14.2851.
    1. Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JEHM. Screening and referral for psychosocial distress in oncologic practice: Use of the Distress Thermometer. Cancer. 2008;113:870–878. doi: 10.1002/cncr.23622.
    1. Arraras JI, Kuljanic-Vlasic K, Bjordal K, Yun YH, Efficace F, Holzner B, Mills J, Greimel E, Krauss O, Velikova G. EORTC QLQ-INFO26: a questionnaire to assess information given to cancer patients a preliminary analysis in eight countries. Psychooncology. 2007;16:249–254. doi: 10.1002/pon.1047.
    1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee M, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376. doi: 10.1093/jnci/85.5.365.
    1. Greimel E, Nordin A, Lanceley A, Creutzberg CL, van de Poll-Franse LV, Radisic VB, Galalae R, Schmalz C, Barlow E, Jensen PT, Waldenström AC, Bergmark K, Chie WC, Kuljanic K, Costantini A, Singer S, Koensgen D, Menon U, Daghofer F. Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24) Eur J Cancer. 2011;47:183–190. doi: 10.1016/j.ejca.2010.08.014.
    1. Greimel E, Bottomley A, Cull A, Waldenstrom AC, Arraras J, Chauvenet L, Holzner B, Kuljanic K, Lebrec J, D'haese S. EORTC Quality of Life Group and the Quality of Life Unit. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer. 2003;39:1402–1408. doi: 10.1016/S0959-8049(03)00307-1.
    1. Bredart A, Bottomley A, Blazeby JM, Conroy T, Coens C, D'Haese S, Chie WC, Hammerlid E, Arraras JI, Efficace F, Rodary C, Schraub S, Costantini M, Costantini A, Joly F, Sezer O, Razavi D, Mehlitz M, Bielska-Lasota M, Aaronson NK. An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32) Eur J Cancer. 2005;41:2120–2131. doi: 10.1016/j.ejca.2005.04.041.
    1. Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60:631–637. doi: 10.1016/j.jpsychores.2005.10.020.
    1. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49:156–163. doi: 10.1002/art.10993.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Michielsen HJ, de Vries J, van Heck GL. Psychometric qualities of a brief self-rated fatigue measure: The Fatigue Assessment Scale. J Psychosom Res. 2003;54:345–352. doi: 10.1016/S0022-3999(02)00392-6.
    1. Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med. 2005;67:89–97. doi: 10.1097/01.psy.0000149256.81953.49.
    1. van de Poll-Franse LV, Mols F, Essink-Bot ML, Haartsen JE, Vingerhoets AJ, Lybeert ML, van den Berg HA, Coebergh JW. Impact of external beam adjuvant radiotherapy on health-related quality of life for long-term survivors of endometrial adenocarcinoma: a population-based study. Int J Radiation Oncology Biol Phys. 2007;69:125–132. doi: 10.1016/j.ijrobp.2007.02.040.
    1. Korfage IJ, Essink-Bot M-L, Mols F, van de Poll-Franse LV, Kruitwagen RFPM, van Ballegooijen M. Health- related quality of life in cervical cancer survivors: a population- based study. Int J Radiation Oncology Biol Phys. 2009;7(3):1501–1509.
    1. Thong MSY, Mols F, Lemmens VEPP, Rutten HJT, Roukema JA, Martijn H, van de Poll-Franse LV. Impact of preoperative radiotherapy on general and disease-specific health status of rectal cancer survivors: a population based study. Int J Radiation Oncology Biol Phys. 2011. in press .
    1. Husson O, Holterhues C, Mols F, Nijsten T, van de Poll-Franse LV. Melanoma survivors are dissatisfied with perceived information about their diagnosis, treatment and follow-up care. British Journal of Dermatology. 2010;163:879–881. doi: 10.1111/j.1365-2133.2010.09895.x.
    1. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41:582–592.
    1. Hox J. Multilevel Analysis: Techniques and Applications. New York: Routledge; 2010.
    1. Twisk JWR. Applied Multilevel Analysis. A Practical Guide. Cambridge: Cambridge University Press; 2006.
    1. Twisk JWR. Applied longitudinal data analysis for epidemiology. A practical guide. Cambridge: Cambridge University Press; 2003.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다